Calidi Biotherapeutics In...
(CLDI)
undefined
undefined%
At close: undefined
1.29
1.67%
Pre-market Jan 07, 2025, 05:00 AM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 |
| PE Ratio | -8.32 | -3.4 | 83.28 | -442.44 |
| PS Ratio | n/a | 1.92K | 628.15 | n/a |
| PB Ratio | -29.53 | -2.12 | 1.31 | -156.21 |
| P/FCF Ratio | -8.82 | -6.34 | -218.82 | -678.32 |
| P/OCF Ratio | -9.01 | -6.55 | -260.45 | -727.65 |
| OCF/S Ratio | n/a | -293.64 | -2.41 | n/a |
| Debt / Equity Ratio | -0.35 | -0.13 | 0.02 | -0.5 |
| Quick Ratio | 0.42 | 0.02 | 3.61 | 0.06 |
| Current Ratio | 0.42 | 0.02 | 3.61 | 0.06 |
| Asset Turnover | n/a | 0.02 | 0.00 | n/a |
| Interest Coverage | -27.12 | -146.38 | -2.9 | -41.55 |
| Return on Equity (ROE) | 3.55 | 0.62 | 0.02 | 0.35 |
| Return on Assets (ROA) | -2.92 | -9.79 | 0.01 | -4.29 |
| Return on Capital (ROIC) | 136.11 | 0.57 | -0.01 | 0.96 |
| Dividend Yield | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | -508.89% | 79.06% | n/a |
| Net Profit Margin | n/a | -56.50K% | 754.29% | n/a |
| Pretax Profit Margin | n/a | -56.48K% | 754.29% | n/a |
| Operating Profit Margin | n/a | -51.40K% | -396.82% | n/a |
| FCF Margin | n/a | -30.32K% | -287.06% | n/a |
| EBITDA Margin | n/a | -55.55K% | -2.10K% | n/a |